Stopping propranolol for infantile hemangioma: gradual vs. sudden stop
Part of Cancer clinical trials.
This study compares two ways to stop giving propranolol to infants whose hemangiomas have fully resolved. The goal is to see which approach works better and which is safer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child has been diagnosed with infantile hemangioma (a type of birthmark caused by blood vessels).
- Your child has taken oral propranolol for at least 6 months.
- The hemangioma is completely or nearly completely gone, with no active blood flow, and has been stable for at least 3 months.
- The doctor has full records, including photos and/or ultrasound results from before treatment.
- You are willing and able to bring your child to follow-up visits as scheduled.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at babies with a type of birthmark called infantile hemangioma (including those that barely grow or have stopped growing). Researchers want to understand the risks and decide on the best treatment.
This trial tests different starting doses of oral propranolol to see which works best and is safest for treating infantile hemangiomas that have ulcers (sores). It may help your child heal faster.
This trial tests whether giving propranolol by mouth to certain very premature babies with early eye changes can stop retinopathy of prematurity from getting worse. It may help reduce the need for eye treatments later on.
This trial studies whether propranolol, a beta-blocker medicine, can help people with VHL who have non-urgent hemangioblastomas in the brain/spinal cord. It aims to see if the medication is safe and beneficial without needing immediate surgery.
This study compares three approaches—pulsed-dye laser, timolol (a medicated skin solution), or watch-and-wait—to see which works best to slow the growth of a hemangioma birthmark in young babies. It may help find a treatment that shrinks or controls the birthmark as early as possible.
This study tests whether a heart medication called propranolol, given intravenously (through an IV), can prevent serious infections in patients who have had bleeding in the brain. You would receive this treatment within 24 hours of your stroke symptoms starting.
Hear when a new Infantile Hemangioma (IH) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.